Meeting
2017 ASCO Annual Meeting
Evaluation of an oral direct anti-Xa anticoagulant, apixaban, for the prevention of venous thromboembolism in patients with myeloma treated with IMiD* compounds: A pilot study (MYELAXAT).
Authors
Brigitte Pegourie
University Hospital Grenoble-Alpes, Grenoble, France
Brigitte Pegourie , Gilles Pernod , Lionel Karlin , Lofti Benboubker , Frederique Orsini , Mourad Tiab , Sophie Auger-Quittet , Philippe Rodon , Bruno Royer , Xavier Leleu , Benoit Bareau , Manuel Cliquennois , Jean-Gabriel Fuzibet , Eric Voog , Karim Belhadj , Olivier Decaux , Philippe Rey , Borhane Slama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Multiple Myeloma
Clinical Trial Registration Number
NCT02066454
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8019)
DOI
10.1200/JCO.2017.35.15_suppl.8019
Abstract #
8019
Poster Bd #
345
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
A retrospective real-world major bleeding (MB) comparison of direct oral anticoagulants (DOAC) and low molecular weight heparin (LMWH) in genitourinary cancer-associated venous thromboembolism (GU-CAVTE) with reported randomized clinical trials (RTC).
First Author: Ulyana Dashkevych
Poster
2016 Genitourinary Cancers Symposium
Safety and efficacy of extended-duration thromboembolic prophylaxis following radical cystectomy.
First Author: Harras B. Zaid
Poster
2021 ASCO Quality Care Symposium
Evaluation of direct oral anticoagulant use for cancer-associated venous thromboembolism (VTE) in lung cancer.
First Author: Leila Rostamnjad
Poster
2020 ASCO Virtual Scientific Program
Venous thromboembolism prophylaxis in ambulatory cancer patients initiating chemotherapy: A cost-effectiveness analysis.
First Author: Emma Ryan